The patient is a 60-year-old man with a history of tobacco use (80 pack-years) who presented with a history of a cough of several months’ duration, occasionally productive of bloodtinged sputum. As part of the evaluation of these symptoms, a chest x-ray was performed, which revealed hilar fullness. As a result of this finding a computed tomography (CT) scan was performed, which revealed a left upper lobe mass surrounding the left main stem bronchus to the level of the carina, and the pulmonary artery without evidence of mediastinal lymphadenopathy. The patient was evaluated by the thoracic surgery service and determined to be unresectable. A positron emission tomography (PET) -CT scan was performed, which revealed increased [18]fluorine fluorodeoxyglucose (FDG) uptake in the left hilar mass, and focally increased uptake in the ascending colon (Fig 1), and no increased uptake in the mediastinal lymph nodes. The differential diagnosis for the focal area of increased FDG uptake in the colon was abscess, adenomatous polyps, hamartomatous adenoma, colonic primary, and metastatic lesion. The patient had a colonoscopy performed 2 years before presentation, which did not reveal any evidence of malignancy. A repeat colonoscopy was performed, which revealed a mass in the ascending colon (Fig 2), and biopsy revealed squamous cell carcinoma consistent with a lung primary. The patient’s clinical stage changed from stage III (T4N0M0) to histologic stage IV, and the patient’s treatment plan changed from chemoradiotherapy with curative intent to chemotherapy. In patients with clinical stage III disease, PET scanning will detect extrathoracic metastases in approximately 25% of patients. Patients who are being considered for surgical resection or chemoradiotherapy with extrathoracic areas of increased FDG uptake detected on PET scan should have a pathologic evaluation of the suspected lesions. A pathologic evaluation of solitary lesions is especially important. A recent retrospective review of patients with non–small-cell lung cancer (NSCLC) found that solitary extrapulmonary lesions were observed on PET-CT imaging in 21% of patients, and 46% of the lesions were either another malignancy, benign tumors, or inflammatory conditions. Previously the colon was not considered a frequent site of metastases for NSCLC; however, PET scanning may reveal a higher incidence of colonic metastases than previously suspected. The optimal management of patients with a solitary lesion detected on PET scan is unclear. Data exist that a proportion of patients with solitary brain or adrenal metastasis may experience prolonged survival with resection of both the primary and solitary metastatic lesion. Whether long-term survival is possible with resection of lung primary and solitary visceral metastasis is not known.